Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) comprises around 6% of all non-Hodgkin’s lymphoma (NHL) diagnoses. In younger patients, age less than 60 to 65 years, aggressive induction often followed by consolidation with autologous stem cell transplant has suggested improved outcomes in this population. Less intensiv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Main Authors: Spurgeon, Stephen E., Till, Brian G., Martin, Peter, Goy, Andre H., Dreyling, Martin P., Gopal, Ajay K., LeBlanc, Michael, Leonard, John P., Friedberg, Jonathan W., Baizer, Lawrence, Little, Richard F., Kahl, Brad S., Smith, Mitchell R.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059122/
https://ncbi.nlm.nih.gov/pubmed/28040733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw263
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares